Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Finished Goods (2016 - 2019)

Prestige Consumer Healthcare has reported Finished Goods over the past 8 years, most recently at $102.6 million for Q1 2019.

  • For Q1 2019, Finished Goods fell 2.51% year-over-year to $102.6 million; the TTM value through Mar 2019 reached $102.6 million, down 2.51%, while the annual FY2019 figure was $102.6 million, 2.51% down from the prior year.
  • Finished Goods for Q1 2019 was $102.6 million at Prestige Consumer Healthcare, up from $99.6 million in the prior quarter.
  • Over five years, Finished Goods peaked at $105.3 million in Q1 2018 and troughed at $66.3 million in Q2 2015.
  • A 5-year average of $86.8 million and a median of $87.9 million in 2016 define the central range for Finished Goods.
  • Biggest five-year swings in Finished Goods: decreased 6.33% in 2015 and later increased 28.79% in 2016.
  • Year by year, Finished Goods stood at $72.6 million in 2015, then rose by 28.12% to $93.0 million in 2016, then increased by 13.2% to $105.3 million in 2017, then fell by 5.35% to $99.6 million in 2018, then grew by 3.02% to $102.6 million in 2019.
  • Business Quant data shows Finished Goods for PBH at $102.6 million in Q1 2019, $99.6 million in Q3 2018, and $105.3 million in Q1 2018.